在HER2 IHC中,双重定位和硬质障碍的解决:一种新的方法来提高诊断灵敏度
Li Luo1, Xi Zhang2,3, Linqiong Chen4
1Department of Clinical Laboratory, Taixing People's Hospital Affiliated to Yangzhou University, Taizhou, China.
BMC cancer
|July 30, 2025
概括
使用亲体和纳米体融合蛋白 (Nby-Aby) 的新型双位测定提高了乳腺癌 (BC) 免疫组织化学 (IHC) 中的HER2检测灵敏度. 这种方法克服了HER2二次体的固体阻碍,提高了个性化治疗的诊断准确性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 免疫组织化学 (IHC) 对乳腺癌 (BC) 诊断和治疗指导至关重要.
- 在HER2 IHC评分中的不一致性,特别是在HER2-低和HER2-阴性病例中,可能导致诊断差异.
- HER2二分化可以掩盖抗体结合部位,影响检测准确度.
研究的目的:
- 开发一种新的测定方法,以在BC中更准确地检测HER2.
- 为了克服由HER2二分化和硬质阻碍引起的传统HER2 IHC测定的局限性.
主要方法:
- 使用 HER2 结合的附体体 (Aby) 和纳米体 (Nby) 针对不同的 HER2 区域构建了融合蛋白 (Nby-Aby).
- 开发了基于人类重链费里丁 (HFn) 的纳米粒子 (Nby-HFn, Aby-HFn) 用于HER2检测.
- 在BC组织中使用组织微阵列 (TMA) 评估Nby-Aby测定性能,并与传统方法进行比较.
主要成果:
- 与传统方法相比,Nby-Aby试验在BC组织中对HER2阳性细胞的检测灵敏度更高.
- 在大多数BC组织中,使用TMAs的Nby-Aby测定观察到显著更高的HER2得分.
- 双重定位和克服硬质障碍是提高诊断精度的有希望的策略.
结论:
- 在BC,Nby-Aby融合蛋白增强了HER2 IHC评估的诊断灵敏度.
- 这种新的方法为更准确的HER2评估提供了一种策略,有可能改善临床决策和患者的治疗结果.
更多相关视频
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.7K
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
285
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Immunocytochemistry and Immunohistochemistry
Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
These...
